Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The FDA intends to award a sole source contract to bioMérieux, Inc. for annual preventive maintenance and calibration of VITEK Instruments across multiple laboratories. The contract includes a 12-month base period and four option years, requiring services to meet ISO 17025 standards by OEM-certified technicians. Interested parties may submit capability statements by April 13, 2026.
The Food and Drug Administration (FDA) Office of Regulatory Testing and Surveillance (ORTS) intends to award a sole source contract to bioMérieux, Inc. (100 Rodolphe Street, Durham, NC 27712) for annual preventive maintenance (PM) and calibration of VITEK Instruments.
Services shall be performed at the following ORTS Laboratories:
The contract will consist of a 12-month base period and four (4) 12-month option years. All services must be performed in accordance with ISO 17025 standards and by Original Equipment Manufacturer (OEM) certified technicians using only OEM parts.
This notice of intent is not a Request for Quote (RFQ). However, responsible sources may submit a capability statement demonstrating their status as an OEM-authorized dealer, distributor, or reseller.
Submissions must include:
Responses to this notice must be sent via email to: Nina.Montgomery@fda.hhs.gov.
This notice will close on April 13, 2026 at 10am EST.
NOTICE OF INTENT TO SOLE SOURCE- BIOMERIEUX is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.